FDA’s accelerated approval program: Is change on the way?

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesHealth Authority meeting and communication strategyNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy